The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal Fragments
Janna Schneppenheim,Ann-Christine Loock,Susann Hüttl,Michaela Schweizer,Renate Lüllmann-Rauch,Hans-Heinrich Oberg,Philipp Arnold,Christian H K Lehmann,Diana Dudziak,Dieter Kabelitz,Ralph Lucius,Ana-Maria Lennon-Duménil,Paul Saftig,Bernd Schröder,Christian H. K. Lehmann
DOI: https://doi.org/10.4049/jimmunol.1601533
2017-05-26
The Journal of Immunology
Abstract:The invariant chain (CD74) mediates assembly and targeting of MHC class II (MHCII) complexes. In endosomes, CD74 undergoes sequential degradation by different proteases, including cathepsin S (CatS) and the intramembrane protease signal peptide peptidase-like 2a (SPPL2a). In their absence, CD74 N-terminal fragments (NTFs) accumulate. In <i>SPPL2a<sup>-/-</sup></i> B cells, such an NTF impairs endosomal trafficking and BCR signal transduction. In mice, this leads to a loss of splenic B cells beyond the transitional stage 1. To gain insight into CD74 determinants and the role of MHCII, we compared B cells from <i>CatS<sup>-/-</sup></i> , <i>SPPL2a<sup>-/-</sup></i> , and SPPL2a-MHCII double-deficient mice. We assessed differentiation of B cells in bone marrow and spleen and analyzed their endosomal morphology, BCR expression, and signal transduction. We demonstrate that MHCII is dispensable for the B cell phenotype of <i>SPPL2a<sup>-/-</sup></i> mice, further supporting a CD74-intrinsic effect. Despite significant vacuolization of endosomal compartments similar to <i>SPPL2a<sup>-/-</sup></i> B cells, <i>CatS<sup>-/-</sup></i> traditional stage 1 B cells show unimpaired degradation of endocytic cargo, have intact BCR signaling, and do not exhibit any relevant defects in maturation. This could indicate that CD74 NTF-induced structural changes of endosomes are not directly involved in these processes. We further found that the block of CD74 degradation in <i>CatS<sup>-/-</sup></i> B cells is incomplete, so that NTF levels are significantly lower than in <i>SPPL2a<sup>-/-</sup></i> B cells. This suggests a dose dependency and threshold for the CD74 NTF-associated impairment of B cell signaling and maturation. In addition, different functional properties of the longer, MHCII-bound CD74 NTF could contribute to the milder phenotype of <i>CatS<sup>-/-</sup></i> B cells.
immunology